TherapeuticsMD
TXMD
49 hedge funds and large institutions have $7.92M invested in TherapeuticsMD in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 3 closing their positions.
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
44% more capital invested
Capital invested by funds: $5.52M → $7.92M (+$2.4M)
11% more funds holding
Funds holding: 44 → 49 (+5)
4.71% more ownership
Funds ownership: 29.25% → 33.96% (+4.7%)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Squadron Capital Management
Westmont,
Illinois
|
+$945K |
| 2 |
Renaissance Technologies
New York
|
+$112K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$90.1K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$61.8K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$24.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.4K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$20.6K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.5K |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
-$11.2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3.58K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$81 | +36 | +23% |
|
TXMD Hedge Fund Activity: Q1 2026 in Review
49 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2026, worth a combined $7.92M — up 44% from $5.52M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TXMD positions and 3 closed out — a net gain of 7 holders — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Squadron Capital Management, opening a new position worth an estimated $945K. The largest seller was Susquehanna International Group, cutting an estimated $31.4K.
- 49 institutional investors held TherapeuticsMD (TXMD) as of Q1 2026, up from 44 in Q4 2025.
- Funds reported $7.92M of TherapeuticsMD stock for Q1 2026, up 44% quarter-over-quarter.
- 10 funds opened new TherapeuticsMD positions in Q1 2026 and 3 closed out, a net change of +7 holders.
- The largest TherapeuticsMD buyer in Q1 2026 was Squadron Capital Management, an estimated $945K added.
- The largest TherapeuticsMD seller in Q1 2026 was Susquehanna International Group, an estimated $31.4K sold.
Based on aggregated 13F filings for Q1 2026.